Cost effectiveness and cost utility analyses of ivabradine (procoralan®) in the treatment of patients with chronic heart failure in Mexico
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.1486
https://www.valueinhealthjournal.com/article/S1098-3015(13)01557-X/fulltext
Section Title :
Cardiovascular Disorders
Section Order :
1050
First Page :
A286
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01557-X&doi=10.1016/j.jval.2013.03.1486